AIDS Research Today is a free monthly online journal that collates and summarizes the latest research about AIDS, including details on testing, treatment, prevention, hiv, life expectancy.

Volume 2 (2005), Issue 7 (July)

1. Granuloma and cryptococcosis.
   J Infect Chemother, 11(3): 115-22. [Abstract] [Full-text]
2. Immunological response to highly active antiretroviral therapy in children with clinically stable HIV-1 infection.
   J Infect Dis, 192(3): 445-55. [Abstract] [Full-text]
3. Changes in human immunodeficiency virus type 1 fitness and genetic diversity during disease progression.
   J Virol, 79(14): 9006-18. [Abstract] [Full-text]
4. The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates.
   J Virol, 79(14): 8979-90. [Abstract] [Full-text]
5. Oligoclonal T cells are infiltrating the brains of children with AIDS: sequence analysis reveals high proportions of identical beta-chain T-cell receptor transcripts.
   Clin Exp Immunol, 141(2): 338-56. [Abstract] [Full-text]
6. Posterior reversible encephalopathic syndrome due to severe hypercalcemia in AIDS.
   Scand J Infect Dis, 37(6): 524-6. [Abstract] [Full-text]
7. Clue to fine-needle aspiration diagnosis of pleural pneumocystoma: neovascularization and Langhans' giant cell reaction.
   Diagn Cytopathol, 33(2): 97-9. [Abstract] [Full-text]
8. Dr. Wouter Basson, Americans, and wild beasts: men's conspiracy theories of HIV/AIDS in the South African Lowveld.
   Med Anthropol, 24(2): 179-208. [Abstract] [Full-text]
9. The aging HIV/AIDS population: fragile social networks.
   Aging Ment Health, 9(3): 246-54. [Abstract] [Full-text]
10. Macrophage chemoattractant protein-1 levels in cerebrospinal fluid correlate with containment of JC virus and prognosis of acquired immunodeficiency syndrome--associated progressive multifocal leukoencephalopathy.
    J Neurovirol, 11(2): 219-24. [Abstract] [Full-text]
11. The effectiveness of media use in health education: evaluation of an HIV/AIDS television campaign in Ethiopia.
    J Health Commun, 10(3): 225-35. [Abstract] [Full-text]
12. Antimicrobial peptides as microbicidal contraceptives: prophecies for prophylactics--a mini review.
    Eur J Contracept Reprod Health Care, 10(1): 32-42. [Abstract] [Full-text]
13. Barriers to HIV/AIDS knowledge and prevention among deaf and hard of hearing people.
    AIDS Care, 17(5): 623-34. [Abstract] [Full-text]
14. Barriers to accessing HIV/AIDS care in North Carolina: rural and urban differences.
    AIDS Care, 17(5): 558-65. [Abstract] [Full-text]
15. AIDS-related discrimination in Asia.
    AIDS Care, 17(4): 413-24. [Abstract] [Full-text]
16. The management of HIV-1 protease inhibitor pharmacokinetic interactions.
    J Antimicrob Chemother, 56(1): 1-5. [Abstract] [Full-text]
17. Adherence to trizivir and tenofovir as a simplified salvage regimen is associated with suppression of viraemia and a decreased cholesterol.
    J Antimicrob Chemother, 56(1): 186-9. [Abstract] [Full-text]
18. The AIDS epidemic in the city of Copenhagen, Denmark: potential years of life lost and impact on life expectancy.
    Scand J Public Health, 33(3): 222-7. [Abstract] [Full-text]
19. Evidence for frequent reinfection with human immunodeficiency virus type 1 of a different subtype.
    J Virol, 79(16): 10701-8. [Abstract] [Full-text]
20. Evolution of human immunodeficiency virus type 1 protease genotypes and phenotypes in vivo under selective pressure of the protease inhibitor ritonavir.
    J Virol, 79(16): 10638-49. [Abstract] [Full-text]
21. Effect of a protease inhibitor-induced genetic bottleneck on human immunodeficiency virus type 1 env gene populations.
    J Virol, 79(16): 10627-37. [Abstract] [Full-text]
22. Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies.
    J Virol, 79(16): 10108-25. [Abstract] [Full-text]

© 2004-2008 AIDS Research Today. All Rights Reserved.